Free Trial
NASDAQ:MDBH

MDB Capital Q2 2024 Earnings Report

MDB Capital logo
$3.08 +0.27 (+9.43%)
Closing price 03:49 PM Eastern
Extended Trading
$3.08 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MDB Capital EPS Results

Actual EPS
-$0.46
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MDB Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MDB Capital Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
7:00AM ET

Earnings Documents

MDB Capital Earnings Headlines

MDB Capital (NASDAQ:MDBH) Stock Price Down 1.3% - Here's What Happened
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel
See More MDB Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MDB Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MDB Capital and other key companies, straight to your email.

About MDB Capital

MDB Capital (NASDAQ:MDBH), through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.

View MDB Capital Profile